Analyze Diet
Transfusion2017; 57(7); 1755-1762; doi: 10.1111/trf.14124

Platelet lysate obtained via plateletpheresis performed in standing and awake equine donors.

Abstract: Platelet preparations containing growth factors, attachment factors, and enzymes are appealing to enhance healing of injured tissues and as an alternative to xenogenic serum in cell culture media. Plateletpheresis is commonly used to collect platelets in human medicine but has not been validated in horses. Plateletpheresis to collect platelet concentrate was performed on six female, mixed breed, chemically restrained horses using commercially available apheresis equipment. Before and immediately after plateletpheresis, we performed physical examinations and collected blood for chemistry and coagulation panels and then again at 8, 16, 24, and 48 hours after the procedure. To produce platelet lysate, the platelet concentrate underwent two freeze-thaw cycles followed by centrifugation and filtration processing. The platelet lysate was then analyzed for cellular debris, fibrinogen, and growth factors. The collected platelet concentration contained a mean platelet yield of 390 × 10 /μL. Donor platelet count decreased from a mean of 193 × 10 /μL to 138 × 10 /μL after plateletpheresis, but no individual was at risk for hemorrhage. Pooled platelet lysate had minimal cellular residue and contained growth factor concentrations at 6.1 ng/mL for transforming growth factor-β1, at 3.5 ng/mL for platelet-derived growth factor-BB, and at 13.8 ng/mL for vascular endothelial growth factor-A. Plateletpheresis using commercially available apheresis equipment is a feasible option for collecting platelet concentrate from equine donors. The lysate generated from the apheresis product contains growth factors and has potential to be used as a fetal bovine serum substitute for cell culture.
Publication Date: 2017-04-25 PubMed ID: 28439897DOI: 10.1111/trf.14124Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study explores the use of plateletpheresis to extract platelet concentrate from horses, with the aim of aiding tissue healing or as an alternative to animal-based cell culture media. The experiment, which used a commercially available apheresis equipment on chemically restrained horses, showed promising results both in terms of feasible extraction, and the presence of potential growth factors in the platelet lysate.

Overview of the Study Design

  • The study was conducted on six female mixed breed horses that were chemically restrained.
  • Plateletpheresis, a process usually used in human medicine to collect platelets, was executed on these subjects using commercially available apheresis equipment.
  • Physical examinations were performed and blood samples were taken before and after the procedure, and subsequently at 8, 16, 24, and 48 hours after plateletpheresis. This facilitated assessing potential procedural impacts and changes over time.
  • The collected platelet concentrate was then subjected to two freeze-thaw cycles, followed by centrifugation and filtration, to produce the platelet lysate.
  • The resulting platelet lysate was examined for cellular debris, fibrinogen, and growth factors to further understand its potential utility.

Findings of the Study

  • The average platelet yield resulting from the plateletpheresis was 390 × 10 /μL, highlighting the procedure as effective for collecting platelet concentrate from horses.
  • There was a decrease in the donor horse’s platelet count after the procedure, from 193 × 10 /μL to 138 × 10 /μL on average. This decrease, however, did not pose a risk of hemorrhage to any of the subjects, suggesting that the procedure is relatively safe.
  • The processed platelet lysate showed minimal cellular residue and contained growth factor concentrations at 6.1 ng/mL for transforming growth factor-β1, 3.5 ng/mL for platelet-derived growth factor-BB, and 13.8 ng/mL for vascular endothelial growth factor-A.

Significance and Impact

  • As the platelet lysate contained relevant growth factors, it presents potential for use as a fetal bovine serum (FBS) substitute in cell culture. This could be an important alternative to traditional methods which could face ethical scrutiny or practical limitations.
  • The study also validates plateletpheresis as a viable method for collecting platelet concentrate from equine donors, which could enhance the healing of injured tissues, particularly in the field of veterinary medicine.

Cite This Article

APA
Sumner SM, Naskou MC, Thoresen M, Copland I, Peroni JF. (2017). Platelet lysate obtained via plateletpheresis performed in standing and awake equine donors. Transfusion, 57(7), 1755-1762. https://doi.org/10.1111/trf.14124

Publication

ISSN: 1537-2995
NlmUniqueID: 0417360
Country: United States
Language: English
Volume: 57
Issue: 7
Pages: 1755-1762

Researcher Affiliations

Sumner, Scarlett M
  • Department of Large Animal Medicine, University of Georgia College of Veterinary Medicine, Athens, Georgia.
Naskou, Maria C
  • Department of Large Animal Medicine, University of Georgia College of Veterinary Medicine, Athens, Georgia.
Thoresen, Merrilee
  • Department of Large Animal Medicine, University of Georgia College of Veterinary Medicine, Athens, Georgia.
Copland, Ian
  • Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.
Peroni, John F
  • Department of Large Animal Medicine, University of Georgia College of Veterinary Medicine, Athens, Georgia.

MeSH Terms

  • Animals
  • Becaplermin
  • Blood Donors
  • Female
  • Horses
  • Humans
  • Platelet Count
  • Plateletpheresis
  • Proto-Oncogene Proteins c-sis / blood
  • Vascular Endothelial Growth Factor A / blood

Citations

This article has been cited 7 times.
  1. Abdelrahman TA, Motawea A, El-Dahhan MS, Abdelghani GM. Chitosan-dipotassium orthophosphate lyophilizate: a novel in situ thermogel carrier system of allogeneic platelet lysate growth factors.. Drug Deliv 2022 Dec;29(1):413-426.
    doi: 10.1080/10717544.2022.2030429pubmed: 35098833google scholar: lookup
  2. Hagen A, Holland H, Brandt VP, Doll CU, Häußler TC, Melzer M, Moellerberndt J, Lehmann H, Burk J. Platelet Lysate for Mesenchymal Stromal Cell Culture in the Canine and Equine Species: Analogous but Not the Same.. Animals (Basel) 2022 Jan 13;12(2).
    doi: 10.3390/ani12020189pubmed: 35049811google scholar: lookup
  3. Gordon J, Álvarez-Narváez S, Peroni JF. Antimicrobial Effects of Equine Platelet Lysate.. Front Vet Sci 2021;8:703414.
    doi: 10.3389/fvets.2021.703414pubmed: 34490395google scholar: lookup
  4. Hagen A, Lehmann H, Aurich S, Bauer N, Melzer M, Moellerberndt J, Patané V, Schnabel CL, Burk J. Scalable Production of Equine Platelet Lysate for Multipotent Mesenchymal Stromal Cell Culture.. Front Bioeng Biotechnol 2020;8:613621.
    doi: 10.3389/fbioe.2020.613621pubmed: 33553119google scholar: lookup
  5. McClain AK, McCarrel TM. The effect of four different freezing conditions and time in frozen storage on the concentration of commonly measured growth factors and enzymes in equine platelet-rich plasma over six months.. BMC Vet Res 2019 Aug 14;15(1):292.
    doi: 10.1186/s12917-019-2040-4pubmed: 31412868google scholar: lookup
  6. Gilbertie JM, Long JM, Schubert AG, Berglund AK, Schaer TP, Schnabel LV. Pooled Platelet-Rich Plasma Lysate Therapy Increases Synoviocyte Proliferation and Hyaluronic Acid Production While Protecting Chondrocytes From Synoviocyte-Derived Inflammatory Mediators.. Front Vet Sci 2018;5:150.
    doi: 10.3389/fvets.2018.00150pubmed: 30023361google scholar: lookup
  7. Naskou MC, Sumner SM, Chocallo A, Kemelmakher H, Thoresen M, Copland I, Galipeau J, Peroni JF. Platelet lysate as a novel serum-free media supplement for the culture of equine bone marrow-derived mesenchymal stem cells.. Stem Cell Res Ther 2018 Mar 22;9(1):75.
    doi: 10.1186/s13287-018-0823-3pubmed: 29566772google scholar: lookup